Amentum (NYSE:AMTM) solidified its status as a cornerstone of the UK’s energy infrastructure on Tuesday, announcing a suite of new contracts from Électricité de France (EDF) worth up to $730 million (£540 million).
Salesforce (NYSE:CRM) announced on Tuesday a monumental shift in its government sector presence, securing a $5.6 billion, 10-year Indefinite Delivery Indefinite Quantity (IDIQ) contract with the U.S. Army.
Micron Technology (NASDAQ:MU) broke ground on a new advanced wafer fabrication facility in Singapore, a strategic expansion with a planned investment of approximately $24 billion (SG$31 billion) over the next 10 years.
Twin Hospitality Group (NASDAQ:TWNP), the parent company of the Twin Peaks and Smokey Bones restaurant brands, announced it has commenced voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Southern District of Texas.
Western Alliance Bancorporation (NYSE:WAL) reported a standout 2025 fiscal year, punctuated by a fourth quarter that saw net income climb 12.6% to $293.2 million.
Polaris (NYSE:PII) reported a fourth-quarter net loss of $303.6 million on Tuesday, a sharp reversal from the prior year, as the company absorbed massive non-cash impairment charges.
PAR Technology (NYSE:PAR) is doubling down on its data-driven "unified commerce" strategy, announcing Monday an agreement to acquire Bridg, the identity resolution and shopper intelligence platform from Cardlytics (NASDAQ:CDLX).
K Wave Media (NASDAQ:KWM) announced Monday the formal closing of its control acquisition of Rabbit Walk, a South Korea-based studio at the intersection of visual effects (VFX), artificial intelligence, and 3D content production.
Hecla Mining (NYSE:HL) is doubling down on its identity as North America’s premier silver producer, announcing on Monday a definitive agreement to sell its Casa Berardi gold mine in Quebec to Orezone Gold.
Papa John’s International (NASDAQ:PZZA) announced Monday that its Board of Directors has declared a quarterly dividend of $0.46 per common share, signaling a commitment to shareholder returns even as the world’s third-largest pizza delivery company undergoes a significant structural pivot.
Neurocrine Biosciences (NASDAQ:NBIX) announced on January 26, 2026, the initiation of its Phase 2 clinical study for NBI-1065890, an investigational compound targeting tardive dyskinesia (TD).
Milestone Pharmaceuticals (NASDAQ:MIST) has officially moved into the commercial stage with the U.S. retail launch of Cardamyst™ (etripamil).
